References
PX'Therapeutics has been working with over 180 biopharmaceutical companies and academic research
centres through service based contracts or research collaborations.
List of non-confidential clients
• Centre d'Immunologie Pierre Fabre (France)
• Alfact
Innovation (France)
• Alizé
Pharma (France)
• BioInfoBank
Institute (Pologne)
• BioMérieux (France)
• Bosch
i Gimpera Foundation (Spain)
• CEA (France)
• CEREP (France)
• CHU
Grenoble (France)
• CNRS (France)
• CRSSA (Ministry
of Defence, France)
• Cyclacel (United
Kingdom)
• DBMS (Grenoble,
France)
• Delta
Crystallon (The Netherlands)
• ENS
Lyon (France)
• European
Synchrotron Research Facility (Grenoble, France)
• ExonHit
Therapeutics (France /USA)
• Fovea
Pharmaceuticals (France)
• Galderma (France)
• Geneuro (France)
• GenHomme consortium (France)
• Genticel (France)
• GREPI,
Research Group on Infl ammatory Process (Grenoble, France)
• Diagnostic
Grifols
• Hopital
Necker (France)
• Hospital
Clínic (Spain)
• ImmunNovative Developments (Spain)
• LFB (France)
• Merck
IRBM (Italia)
• Mérial (France)
• Michigan
University (USA)
• Mymetics
Corp. (USA)
• Netris
Pharma (France)
• OPI (France)
• Pangenetics (UK)
• Pronota (Belgium)
• Pfizer (France)
• Sisene (France)
)
• Trophos (France)
• TSI (USA)
• University
of New South Wales (Australia)
• Viventia
h (Canada)
• Clínic
Foundation (Spain)
• IGS,
&Genomic Data Group (Marseille, France)
• Innate Pharma (France)
• Institute
of Stuctural Biology (Grenoble, France)
• INSERM (France)
• INSERM/UJF - Neurodegeneration (France)
• Institut
Necker (France)
• Invivogen (France)
• Laboratoire
français du fractionnement et des biotechnologies (LFB) (France)
• Oncomax (Russia)
• Institute
of Stuctural Biology (Grenoble, France)
• IGS,
Structural & Genomic Data Group (Marseille, France)
• IMGT (Montpellier, France)